|
|
|
Fiscal Period: March
|
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
| Capitalization1 |
1 826 125 | 2 060 088 | 2 175 972 | 2 513 330 | - | - |
| Entreprise Value (EV)1 |
1 512 022 | 1 929 453 | 2 404 050 | 2 715 413 | 2 695 721 | 2 634 711 |
| P/E ratio |
13,2x | 15,4x | 17,8x | 19,0x | 16,7x | 14,9x |
| Yield |
1,77% | 1,59% | 1,75% | 1,52% | 1,60% | 1,73% |
| Capitalization / Revenue |
0,75x | 0,85x | 0,94x | 1,15x | 1,07x | 1,04x |
| EV / Revenue |
0,62x | 0,79x | 1,04x | 1,24x | 1,15x | 1,09x |
| EV / EBITDA |
5,85x | 5,68x | 7,77x | 9,83x | 8,07x | 7,32x |
| Price to Book |
0,88x | 1,01x | 1,11x | 1,23x | 1,18x | 1,13x |
| Nbr of stocks (in thousands) |
430 183 | 409 235 | 400 068 | 399 766 | - | - |
| Reference price (JPY) |
4 245 | 5 034 | 5 439 | 6 287 | 6 287 | 6 287 |
| Last update |
05/18/2018 | 05/08/2019 | 05/22/2020 | 01/15/2021 | 01/15/2021 | 01/15/2021 |
|
1 JPY in Million Estimates
|
|
| Income Statement Evolution | |
|
|
|
| Annual Income Statement Data |
|
|
Fiscal Period: March
|
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
| Net sales1 |
2 433 365 | 2 431 489 | 2 315 141 | 2 184 507 | 2 340 752 | 2 414 713 |
| EBITDA1 |
258 321 | 339 759 | 309 223 | 276 345 | 334 195 | 360 157 |
| Operating profit (EBIT)1 |
130 679 | 209 827 | 186 570 | 147 253 | 199 852 | 221 286 |
| Operating Margin |
5,37% | 8,63% | 8,06% | 6,74% | 8,54% | 9,16% |
| Pre-Tax Profit (EBT)1 |
197 807 | 212 762 | 173 071 | 183 546 | 206 000 | 225 967 |
| Net income1 |
140 694 | 138 106 | 124 987 | 131 859 | 148 648 | 164 855 |
| Net margin |
5,78% | 5,68% | 5,40% | 6,04% | 6,35% | 6,83% |
| EPS2 |
323 | 327 | 306 | 331 | 377 | 421 |
| Dividend per Share2 |
75,0 | 80,0 | 95,0 | 95,6 | 101 | 109 |
| Last update |
05/18/2018 | 05/08/2019 | 05/22/2020 | 01/15/2021 | 01/15/2021 | 01/15/2021 |
|
1 JPY in Million 2 JPY Estimates
|
|
|
|
|
Fiscal Period: March
|
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
| Net Debt1 |
- | - | 228 078 | 202 084 | 182 391 | 121 381 |
| Net Cash position1 |
314 103 | 130 635 | - | - | - | - |
| Leverage (Debt / EBITDA) |
-1,22x | -0,38x | 0,74x | 0,73x | 0,55x | 0,34x |
| Free Cash Flow1 |
149 366 | 40 758 | 170 990 | 161 409 | 134 235 | 170 713 |
| ROE (Net Profit / Equities) |
6,80% | 6,70% | 6,30% | 6,64% | 7,28% | 7,76% |
| Shareholders' equity1 |
2 069 029 | 2 061 284 | 1 983 921 | 1 984 805 | 2 040 952 | 2 123 692 |
| ROA (Net Profit / Asset) |
5,63% | 6,16% | 5,14% | 4,06% | 4,63% | 4,95% |
| Assets1 |
2 498 735 | 2 241 908 | 2 432 416 | 3 249 008 | 3 212 421 | 3 330 105 |
| Book Value Per Share2 |
4 833 | 4 977 | 4 887 | 5 092 | 5 309 | 5 554 |
| Cash Flow per Share2 |
615 | 634 | 607 | 625 | 602 | 643 |
| Capex1 |
63 043 | 75 372 | 84 677 | 96 755 | 97 468 | 98 205 |
| Capex / Sales |
2,59% | 3,10% | 3,66% | 4,43% | 4,16% | 4,07% |
| Last update |
05/18/2018 | 05/08/2019 | 05/22/2020 | 01/15/2021 | 01/15/2021 | 01/15/2021 |
|
1 JPY in Million 2 JPY Estimates
|
|
|
|
|
|
Financial data source
© 2021 S&P Global Market Intelligence
|
|
|
Fujifilm : says will invest $2 billion in new large-scale cell culture production site in U.S |
Capitalization (JPY) 2 513 329 634 162 Capitalization (USD) 24 215 294 526 Net sales (JPY) 2 315 141 000 000 Net sales (USD) 22 304 068 394 Number of employees 73 906 Sales / Employee (JPY) 31 325 481 Sales / Employee (USD) 301 790 Free-Float capitalization (JPY) 1 858 195 345 856 Free-Float capitalization (USD) 17 903 241 571 Avg. Exchange 20 sessions (JPY) 14 295 003 380 Avg. Exchange 20 sessions (USD) 137 718 063 Average Daily Capital Traded 0,6%
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Evolution Valeur d'Entreprise / EBITDA
|
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
